Want to see TLSI full AI Analyst Report?
TriSalus Life Sciences (TLSI) Income Statement
TriSalus Life Sciences Income Statement
Last quarter (Q2 2026), TriSalus Life Sciences's total revenue was $11.41M, an increase of 1.73% from the same quarter last year. In Q2, TriSalus Life Sciences's net income was $-9.19M. See TriSalus Life Sciences’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Mar 24 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 45.15M | $ 29.43M | $ 18.51M | $ 12.40M | $ 8.40M | |
| $ 38.19M | $ 25.33M | $ 15.91M | $ 10.14M | $ 7.21M | |
| $ 65.13M | $ 61.49M | $ 70.38M | $ 46.58M | $ 31.24M | |
| Depreciation and Amortization | $ 626.00K | $ 744.00K | $ 684.00K | $ 398.00K | $ 464.00K |
| $ -33.05M | $ -32.38M | $ -58.65M | $ -46.78M | $ -26.62M | |
| $ -26.95M | $ -36.16M | $ -54.48M | $ -36.44M | $ -24.03M | |
| $ -12.27M | $ 6.13M | $ -4.88M | $ -10.74M | $ -4.81M | |
| $ -39.22M | $ -30.04M | $ -59.35M | $ -47.18M | $ -28.84M | |
| $ -39.23M | $ -33.23M | $ -59.36M | $ -47.19M | $ -28.84M | |
| Per Share Metrics | |||||
| Basic EPS | $ -1.84 | $ -1.25 | $ -2.23 | $ -1.59 | $ -0.92 |
| Diluted EPS | $ -1.84 | $ -1.25 | $ -2.23 | $ -1.59 | $ -0.92 |
| Weighted Average Shares Outstanding | 37.90M | 26.50M | 26.47M | 29.61M | 31.25M |
| Weighted Average Shares Outstanding (Diluted) | 37.90M | 26.50M | 26.47M | 29.61M | 31.25M |
Currency in USD
